vrt106
Biologicalexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 30, 2024 (NCT06368921)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusSupplementation
Oncolytic virus supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07093814 | Phase 1/Phase 2 (Phase 2) | Sep 2, 2025 | Sun Yat-Sen University, Virotech |
| NCT06866977 | Phase 1/Phase 2 (Phase 2) | Mar 12, 2025 | Central South University, Virotech |
| NCT06826313 | Phase 1 | Mar 1, 2025 | Sun Yat-Sen University, Virotech |
| NCT06758544 | Phase 1/Phase 2 (Phase 2) | Dec 12, 2024 | Shantou University, Virotech |
| NCT06368921 | Phase 1 | Apr 30, 2024 | Virotech |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Virotech | For profit | 5 | 3 | 2 | 2024 |
| Sun Yat-Sen University | Academic/Hospital | 2 | 0 | 2 | 2025 |
| Central South University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Shantou University | Academic/Hospital | 1 | 1 | 1 | 2024 |
4 organizations
Page 1 / 1